Li, X., Liu, F., Liu, B., Yang, J., Han, S. (2025). Vascular endothelial growth factor receptor (VEGFR) -tyrosine kinase inhibitors combined with programmed death receptor-1 (PD-1) inhibitors as third- or later-line treatment in patients with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): A retrospective study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.68